Investor Overview

Investor Presentation
Financial News
Nov 25, 2019

- Tumor control rate of 82% in recurrent glioblastoma following one treatment with MDNA55 - Median overall survival of 15 months in patients over-expressing the IL4R - Meetings with regulatory...

Nov 21, 2019

Results presented at the 3rd SNO-SCIDOT Joint Conference show 12-month survival benefit of over 111% in patients over-expressing the IL-4 receptor TORONTO and HOUSTON, Nov. 21, 2019 /CNW/ -...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Tuesday, December 10, 2019 - Thursday, December 12, 2019

Title: 12th Annual LD Micro Main Event Date: December 10-12, 2019 Location: Luxe Sunset | Bel-Air, CA

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields